2-(3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)acetic acid; Fmoc-(R,S)-3-amino-N-1-carboxymethyl-2-oxo-5-phenyl-1,4-benzodiazepine; 1H-1,4-Benzodiazepine-1-acetic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,3-dihydro-2-oxo-5-phenyl-; 2-(3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)acetic acid
Pyrrolobenzodiazepine Impurity 1 is a fully characterized chemical compound used as a reference standard of API Pyrrolobenzodiazepine. The standard offered is compliant with regulatory guidelines. Pyrrolobenzodiazepine Impurity 1 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 204322-85-0
